The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends, and Updates (7/12/18)
- Updated Guideline: Human Papillomavirus (HPV) in Patients with HIV (7/11/2018)
- Slide Set: HPV in Patients with HIV (7/11/2018)
- Slide Set: Management of Periodontal Disease in Patients with HIV (7/3/2018)
- Update: Selecting an Initial ART Regimen (6/22/2018)
- Slide Set: Selecting an Initial ART Regimen (6/22/2018)
- Update: PrEP to Prevent HIV Acquisition (5/17/18)
- Medscape Commentary: Syphilis Screening: Make it Routine in HIV Care (4/25/18)
- AIDSource: HIV Conference Abstract Database Now Available (7/12/18)
- AETC NCRC Updates (7/11/18)
- NYC Health Information: Preventing, Identifying, and Managing HBV Infection (7/6/18)
- FDA: Revisions to VEMLIDY (tenofovir alafenamide) Labeling (7/5/18)
- AIDSinfo Updates Consumer Fact Sheets on HIV & Opportunistic Infections, Coinfections & Conditions (6/28/18)
Is High-Sensitivity CRP a Useful Cardiovascular Risk Predictor for Women with HIV? Risk of cardiovascular disease (CVD) and ischemic stroke in women with HIV appears to be greater than in men with HIV and in women who do not have HIV. Read more
Chronic Comorbidities among People Living with HIV Infection: As a result of potent and tolerable antiretroviral therapy (ART), people with HIV infection (PLWH) are living longer. However, rates of chronic, non-communicable end-organ diseases are higher in PLWH than in people of similar ages who do not have HIV infection. Read more
- 7/21/18: STI 2018: Understanding & Addressing the HIV & STI Syndemics (Amsterdam, NL)
- 7/22/18: TB 2018 (Amsterdam, NL)
- 7/23/18: International AIDS Conference 2018 (Amsterdam, NL)
- 8/17/18: CEI: From Stigma to Action: Addressing Substance Use, Harm Reduction & Healthcare (New York, NY)
- 8/27/18: CDC: 2018 STD Prevention Conference (Washington, DC)
- 7/18/18: CEI This Month in HIV: PrEP
- 7/18/18: ACE TA Center: Planning Ahead for Open Enrollment: What's New for 2019?
- 7/24/18: Mountain West AETC: How Does the Vaginal Environment Impact HIV/STI Risk?
- 7/25/18: CEI STD ECHO: PEP at the Pharmacy in NYS
- 8/01/18: CEI HIV ECHO: Status Neutral HIV Screening